Piccinini Laura 4
4 · ANGIODYNAMICS INC · Filed Jul 21, 2023
Insider Transaction Report
Form 4
Piccinini Laura
SVP International
Transactions
- Award
Performance Right
2023-07-19+28,336→ 28,336 total→ Common Stock (28,336 underlying) - Award
Common Stock
2023-07-19+14,168→ 20,122 total - Award
Non-Qualified Stock Option (right to buy)
2023-07-19+29,322→ 29,322 totalExercise: $8.92From: 2024-07-19Exp: 2033-07-19→ Common Stock (29,322 underlying)
Footnotes (3)
- [F1]The acquisition of 14,168 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 14,168 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 19, 2024, such that 25% of the restricted stock units will vest on each of July 19, 2024, 2025, 2026 and 2027.
- [F2]Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited.
- [F3]These stock options vest in four equal annual installments beginning on July 19, 2024, such that 25% of the options will vest on each of July 19, 2024, 2025, 2026 and 2027.